Ep 10 How The Australian Injectable Industry Started | Richard Arnott

Episode 10 hosts Richard Arnott (General Manager of Mondeal Aesthetics from Sydney, Australia) Richard has over 15 years of experience in the skin and facial aesthetic industry, having also previously been the General Manager of Q-MED/Galderma. We discuss the Australian market when the first filler was launched and get an insight into Mondeal's more novel products. 0:00 Introduction  1:03 Meet Richard Arnott 3:19 Career Background and Entry Into Pharmaceuticals 5:16 Early Experience in Regenerative Medicine 9:44 Autologous Cell Therapy Explained 11:56 Challenges Commercializing Regenerative Treatments 14:01 Logistics and Cost Barriers in Early Biologic Therapies 16:30 Variability of Results in PRP and Stem Cells 18:16 Ethics and Evidence in Regenerative Medicine 23:53 Transition Into Aesthetic Industry With QMed 27:02 Early Days of Dermal Fillers and Limited Competition 30:22 Evolution From Lines to Volume Restoration 33:44 Growth of Aesthetic Clinics and Market Demand 37:39 Financial Incentives and Industry Expansion 41:39 Skill and Artistry Required for Injectors 45:36 Leaving Corporate Structure to Start Independent Business 48:05 Founding and Building Mondial Aesthetics 51:43 Identifying Market Needs and Product Selection 57:32 Innovation and Learning From Korean Aesthetic Market 1:01:04 Introduction to Thread Lift Technology 1:03:30 How Thread Lifts Work 1:07:48 Lifting Threads Versus Mono Threads 1:12:19 Patient Selection and Realistic Outcomes 1:16:00 Combining Threads With Fillers 1:19:56 Longevity and Maintenance of Thread Treatments 1:22:22 Safety and Clean Procedure Standards 1:25:07 Launching Threads in Australia and Training Requirements 1:27:43 Doctor Only Device Considerations 1:30:37 Introducing Beauty Booster Skin Treatment 1:33:59 Cross Linked Versus Uncross Linked Hyaluronic Acid 1:36:53 Importance of Skin Quality Before Volume Treatments 1:39:25 Mechanism of Skin Hydration and Dermal Repair 1:42:10 Automated Injection Devices and Precision Delivery 1:44:30 Patient Experience and Treatment Tolerance 1:48:40 Treatment Protocol and Maintenance Schedule 1:53:30 Educating Patients on Skin First Approach 1:55:45 Marketing and Adoption Challenges for Skin Treatments 2:00:30 Use of Injection Devices and Filler Pens 2:03:05 Benefits of Mechanized Injection Systems 2:05:40 Skincare and Post Treatment Products 2:10:55 Business Advice for Clinic Owners 2:13:30 Hiring, Retention and Profit Sharing Strategies 2:18:00 Future of Regenerative Medicine in Aesthetics 2:20:15 Final Thoughts and Contact Information ALL IA LINKS AND CONTACT INFORMATION